Ovarian Cancer

(asked on 17th November 2014) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what assessment he has made of the effectiveness of the implementation of the National Institute for Health and Care Excellence's most recent guidelines for genetic testing for ovarian cancer.


Answered by
 Portrait
Jane Ellison
This question was answered on 20th November 2014

The National Institute for Health and Care Excellence’s clinical guideline on familial breast cancer, published in June 2013, recommends that women with breast or ovarian cancer should be offered genetic testing if their combined BRCA1 and BRCA2 mutation carrier possibility is 10% or more.

NHS England is considering moving to a lower threshold as part of the annual prioritisation process for funding in 2015-16.

We intend to raise the matter of genetic testing for ovarian cancer patients with the Health Ministers of Scotland, Wales, and Northern Ireland in our next regular meeting with them.

Reticulating Splines